Ledger.Open graph →
SEC Form D · filed November 15, 2018

Lexaria Bioscience Corp

Offering
$310K
Sold
$310K
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
KELOWNA, British Columbia, Canada
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (12)

Nicholas W. Baxter · Aberdeen, Scotland, United KingdomDirectorTed W. Mckechnie · Kitchener, Ontario, CanadaDirectorJohn M. Docherty · Vancouver, British Columbia, CanadaExec · DirectorChristopher Bunka · Vancouver, British Columbia, CanadaExec · DirectorAllan W. Spissinger · Kelowna, British Columbia, CanadaExecNersi Nazari · San Jose, CADirectorJames Mccluney · San Jose, CADirectorChristopher J. Grasso · Hamilton, BermudaDirectorPatrick J. Mclaughlin · Hamilton, BermudaDirectorJohn M. Docherty · Vancouver, British Columbia, CanadaExec · DirectorChristopher Bunka · Vancouver, British Columbia, CanadaExec · DirectorAllan W. Spissinger · Kelowna, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗